Skip to content
Screener

Abbott ABT Q1 2026 earnings

Reported April 16, 2026 · Before market open

Revenue$11.2BBeat by $164.4M
EPS$1.15Beat by $0.01
Revenue estimate$11.0B
EPS estimate$1.14

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$13.0B
EPS estimate$1.42

Financials

Q1 2026

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$178.41B-22.5%
Enterprise value$205.65B-13.1%
P/E28.4×+11.4×
P/S4×-1.5×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Segments

By segment

See full
Medical Devices$5.5B+13.2%
Diagnostic Products$2.2B+6.1%
Nutritional Products$2.0B-6.0%
Established Pharmaceuticals$1.4B+13.2%

FAQ

When did Abbott report Q1 2026 earnings?
Abbott (ABT) reported Q1 2026 earnings on April 16, 2026 before market open.
What were Abbott's Q1 2026 revenue and EPS?
Abbott reported revenue of $11.2B and eps of $1.15 for Q1 2026.
Did Abbott beat estimates in Q1 2026?
Revenue beat the consensus estimate of $11.0B by $164.4M. EPS beat the consensus estimate of $1.14 by $0.01.
How did Abbott's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.8% from $10.4B a year earlier and eps grew 5.5% from $1.09.
Where can I find Abbott's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-025365) and the 10-Q periodic report (0001628280-26-028357) directly on SEC EDGAR. The filing index links above go to sec.gov.